
Global Gene Sequencing Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Gene Sequencing market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Gene Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Gene Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Gene Sequencing market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Gene Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Gene Sequencing market include Novogene, Roche, Mgi Tech, BGI Genomics, Berry Genomics, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore and Natera, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Gene Sequencing, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Gene Sequencing, also provides the value of main regions and countries. Of the upcoming market potential for Gene Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Sequencing revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Gene Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Gene Sequencing company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Gene Sequencing Segment by Company
Novogene
Roche
Mgi Tech
BGI Genomics
Berry Genomics
Thermo Fisher Scientific
Pacific Biosciences
Oxford Nanopore
Natera
Macrogen
LabCorp
Illumina
Eurofins Scientific
Azenta Life Sciences
Gene Sequencing Segment by Type
Next-generation Sequencing
Third and Fourth Generation Sequencing
First-generation Sequencing
Gene Sequencing Segment by Application
Clinical Research
Academic Research
Hospital Clinic
Pharmaceuticals and Biotechnology
Others
Gene Sequencing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Gene Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Sequencing key companies, revenue, market share, and recent developments.
3. To split the Gene Sequencing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Sequencing significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Sequencing industry.
Chapter 3: Detailed analysis of Gene Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Sequencing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
According to APO Research, the global Gene Sequencing market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Gene Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Gene Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Gene Sequencing market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Gene Sequencing is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Gene Sequencing market include Novogene, Roche, Mgi Tech, BGI Genomics, Berry Genomics, Thermo Fisher Scientific, Pacific Biosciences, Oxford Nanopore and Natera, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Gene Sequencing, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Gene Sequencing, also provides the value of main regions and countries. Of the upcoming market potential for Gene Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Sequencing revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Gene Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Gene Sequencing company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Gene Sequencing Segment by Company
Novogene
Roche
Mgi Tech
BGI Genomics
Berry Genomics
Thermo Fisher Scientific
Pacific Biosciences
Oxford Nanopore
Natera
Macrogen
LabCorp
Illumina
Eurofins Scientific
Azenta Life Sciences
Gene Sequencing Segment by Type
Next-generation Sequencing
Third and Fourth Generation Sequencing
First-generation Sequencing
Gene Sequencing Segment by Application
Clinical Research
Academic Research
Hospital Clinic
Pharmaceuticals and Biotechnology
Others
Gene Sequencing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Gene Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Gene Sequencing key companies, revenue, market share, and recent developments.
3. To split the Gene Sequencing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Gene Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Gene Sequencing significant trends, drivers, influence factors in global and regions.
6. To analyze Gene Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Sequencing industry.
Chapter 3: Detailed analysis of Gene Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Gene Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Gene Sequencing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Table of Contents
196 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gene Sequencing Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Gene Sequencing Market Size (2020-2031)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Gene Sequencing Market Dynamics
- 2.1 Gene Sequencing Industry Trends
- 2.2 Gene Sequencing Industry Drivers
- 2.3 Gene Sequencing Industry Opportunities and Challenges
- 2.4 Gene Sequencing Industry Restraints
- 3 Gene Sequencing Market by Company
- 3.1 Global Gene Sequencing Company Revenue Ranking in 2024
- 3.2 Global Gene Sequencing Revenue by Company (2020-2025)
- 3.3 Global Gene Sequencing Company Ranking (2023-2025)
- 3.4 Global Gene Sequencing Company Manufacturing Base and Headquarters
- 3.5 Global Gene Sequencing Company Product Type and Application
- 3.6 Global Gene Sequencing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Gene Sequencing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.7.3 2024 Gene Sequencing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
- 4 Gene Sequencing Market by Type
- 4.1 Gene Sequencing Type Introduction
- 4.1.1 Next-generation Sequencing
- 4.1.2 Third and Fourth Generation Sequencing
- 4.1.3 First-generation Sequencing
- 4.2 Global Gene Sequencing Sales Value by Type
- 4.2.1 Global Gene Sequencing Sales Value by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Gene Sequencing Sales Value by Type (2020-2031)
- 4.2.3 Global Gene Sequencing Sales Value Share by Type (2020-2031)
- 5 Gene Sequencing Market by Application
- 5.1 Gene Sequencing Application Introduction
- 5.1.1 Clinical Research
- 5.1.2 Academic Research
- 5.1.3 Hospital Clinic
- 5.1.4 Pharmaceuticals and Biotechnology
- 5.1.5 Others
- 5.2 Global Gene Sequencing Sales Value by Application
- 5.2.1 Global Gene Sequencing Sales Value by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Gene Sequencing Sales Value by Application (2020-2031)
- 5.2.3 Global Gene Sequencing Sales Value Share by Application (2020-2031)
- 6 Gene Sequencing Regional Value Analysis
- 6.1 Global Gene Sequencing Sales Value by Region: 2020 VS 2024 VS 2031
- 6.2 Global Gene Sequencing Sales Value by Region (2020-2031)
- 6.2.1 Global Gene Sequencing Sales Value by Region: 2020-2025
- 6.2.2 Global Gene Sequencing Sales Value by Region (2026-2031)
- 6.3 North America
- 6.3.1 North America Gene Sequencing Sales Value (2020-2031)
- 6.3.2 North America Gene Sequencing Sales Value Share by Country, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Gene Sequencing Sales Value (2020-2031)
- 6.4.2 Europe Gene Sequencing Sales Value Share by Country, 2024 VS 2031
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Gene Sequencing Sales Value (2020-2031)
- 6.5.2 Asia-Pacific Gene Sequencing Sales Value Share by Country, 2024 VS 2031
- 6.6 South America
- 6.6.1 South America Gene Sequencing Sales Value (2020-2031)
- 6.6.2 South America Gene Sequencing Sales Value Share by Country, 2024 VS 2031
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Gene Sequencing Sales Value (2020-2031)
- 6.7.2 Middle East & Africa Gene Sequencing Sales Value Share by Country, 2024 VS 2031
- 7 Gene Sequencing Country-level Value Analysis
- 7.1 Global Gene Sequencing Sales Value by Country: 2020 VS 2024 VS 2031
- 7.2 Global Gene Sequencing Sales Value by Country (2020-2031)
- 7.2.1 Global Gene Sequencing Sales Value by Country (2020-2025)
- 7.2.2 Global Gene Sequencing Sales Value by Country (2026-2031)
- 7.3 USA
- 7.3.1 USA Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.3.2 USA Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.3.3 USA Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.4 Canada
- 7.4.1 Canada Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.4.2 Canada Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.4.3 Canada Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.5 Mexico
- 7.5.1 Mexico Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.5.2 Mexico Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.5.3 Mexico Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.6 Germany
- 7.6.1 Germany Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.6.2 Germany Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Germany Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.7 France
- 7.7.1 France Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.7.2 France Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.7.3 France Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.8 U.K.
- 7.8.1 U.K. Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.8.2 U.K. Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.8.3 U.K. Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.9 Italy
- 7.9.1 Italy Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.9.2 Italy Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.9.3 Italy Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.10 Spain
- 7.10.1 Spain Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.10.2 Spain Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.10.3 Spain Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.11 Russia
- 7.11.1 Russia Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.11.2 Russia Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Russia Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.12 Netherlands
- 7.12.1 Netherlands Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.12.2 Netherlands Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Netherlands Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.13.2 Nordic Countries Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Nordic Countries Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.14 China
- 7.14.1 China Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.14.2 China Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.14.3 China Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.15 Japan
- 7.15.1 Japan Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.15.2 Japan Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Japan Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.16 South Korea
- 7.16.1 South Korea Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.16.2 South Korea Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.16.3 South Korea Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.17 India
- 7.17.1 India Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.17.2 India Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.17.3 India Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.18 Australia
- 7.18.1 Australia Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.18.2 Australia Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.18.3 Australia Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.19.2 Southeast Asia Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.19.3 Southeast Asia Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.20 Brazil
- 7.20.1 Brazil Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.20.2 Brazil Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Brazil Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.21 Argentina
- 7.21.1 Argentina Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.21.2 Argentina Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Argentina Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.22 Chile
- 7.22.1 Chile Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.22.2 Chile Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Chile Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.23 Colombia
- 7.23.1 Colombia Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.23.2 Colombia Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Colombia Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.24 Peru
- 7.24.1 Peru Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.24.2 Peru Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Peru Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.25.2 Saudi Arabia Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Saudi Arabia Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.26 Israel
- 7.26.1 Israel Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.26.2 Israel Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Israel Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.27 UAE
- 7.27.1 UAE Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.27.2 UAE Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.27.3 UAE Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.28 Turkey
- 7.28.1 Turkey Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.28.2 Turkey Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Turkey Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.29 Iran
- 7.29.1 Iran Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.29.2 Iran Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.29.3 Iran Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 7.30 Egypt
- 7.30.1 Egypt Gene Sequencing Sales Value Growth Rate (2020-2031)
- 7.30.2 Egypt Gene Sequencing Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Egypt Gene Sequencing Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Novogene
- 8.1.1 Novogene Comapny Information
- 8.1.2 Novogene Business Overview
- 8.1.3 Novogene Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.1.4 Novogene Gene Sequencing Product Portfolio
- 8.1.5 Novogene Recent Developments
- 8.2 Roche
- 8.2.1 Roche Comapny Information
- 8.2.2 Roche Business Overview
- 8.2.3 Roche Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.2.4 Roche Gene Sequencing Product Portfolio
- 8.2.5 Roche Recent Developments
- 8.3 Mgi Tech
- 8.3.1 Mgi Tech Comapny Information
- 8.3.2 Mgi Tech Business Overview
- 8.3.3 Mgi Tech Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.3.4 Mgi Tech Gene Sequencing Product Portfolio
- 8.3.5 Mgi Tech Recent Developments
- 8.4 BGI Genomics
- 8.4.1 BGI Genomics Comapny Information
- 8.4.2 BGI Genomics Business Overview
- 8.4.3 BGI Genomics Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.4.4 BGI Genomics Gene Sequencing Product Portfolio
- 8.4.5 BGI Genomics Recent Developments
- 8.5 Berry Genomics
- 8.5.1 Berry Genomics Comapny Information
- 8.5.2 Berry Genomics Business Overview
- 8.5.3 Berry Genomics Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.5.4 Berry Genomics Gene Sequencing Product Portfolio
- 8.5.5 Berry Genomics Recent Developments
- 8.6 Thermo Fisher Scientific
- 8.6.1 Thermo Fisher Scientific Comapny Information
- 8.6.2 Thermo Fisher Scientific Business Overview
- 8.6.3 Thermo Fisher Scientific Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.6.4 Thermo Fisher Scientific Gene Sequencing Product Portfolio
- 8.6.5 Thermo Fisher Scientific Recent Developments
- 8.7 Pacific Biosciences
- 8.7.1 Pacific Biosciences Comapny Information
- 8.7.2 Pacific Biosciences Business Overview
- 8.7.3 Pacific Biosciences Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.7.4 Pacific Biosciences Gene Sequencing Product Portfolio
- 8.7.5 Pacific Biosciences Recent Developments
- 8.8 Oxford Nanopore
- 8.8.1 Oxford Nanopore Comapny Information
- 8.8.2 Oxford Nanopore Business Overview
- 8.8.3 Oxford Nanopore Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.8.4 Oxford Nanopore Gene Sequencing Product Portfolio
- 8.8.5 Oxford Nanopore Recent Developments
- 8.9 Natera
- 8.9.1 Natera Comapny Information
- 8.9.2 Natera Business Overview
- 8.9.3 Natera Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.9.4 Natera Gene Sequencing Product Portfolio
- 8.9.5 Natera Recent Developments
- 8.10 Macrogen
- 8.10.1 Macrogen Comapny Information
- 8.10.2 Macrogen Business Overview
- 8.10.3 Macrogen Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.10.4 Macrogen Gene Sequencing Product Portfolio
- 8.10.5 Macrogen Recent Developments
- 8.11 LabCorp
- 8.11.1 LabCorp Comapny Information
- 8.11.2 LabCorp Business Overview
- 8.11.3 LabCorp Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.11.4 LabCorp Gene Sequencing Product Portfolio
- 8.11.5 LabCorp Recent Developments
- 8.12 Illumina
- 8.12.1 Illumina Comapny Information
- 8.12.2 Illumina Business Overview
- 8.12.3 Illumina Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.12.4 Illumina Gene Sequencing Product Portfolio
- 8.12.5 Illumina Recent Developments
- 8.13 Eurofins Scientific
- 8.13.1 Eurofins Scientific Comapny Information
- 8.13.2 Eurofins Scientific Business Overview
- 8.13.3 Eurofins Scientific Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.13.4 Eurofins Scientific Gene Sequencing Product Portfolio
- 8.13.5 Eurofins Scientific Recent Developments
- 8.14 Azenta Life Sciences
- 8.14.1 Azenta Life Sciences Comapny Information
- 8.14.2 Azenta Life Sciences Business Overview
- 8.14.3 Azenta Life Sciences Gene Sequencing Revenue and Gross Margin (2020-2025)
- 8.14.4 Azenta Life Sciences Gene Sequencing Product Portfolio
- 8.14.5 Azenta Life Sciences Recent Developments
- 9 Concluding Insights
- 10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.